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Cellular signal transduction is governed by multiple feedback mechanisms to elicit robust cellular
decisions. The speciﬁc contributions of individual feedback regulators, however, remain unclear.
Based on extensive time-resolved data sets in primary erythroid progenitor cells, we established a
dynamic pathway model to dissect the roles of the two transcriptional negative feedback regulators
of the suppressor of cytokine signaling (SOCS) family, CIS and SOCS3, in JAK2/STAT5 signaling.
Facilitated by the model, we calculated the STAT5 response for experimentally unobservable Epo
concentrations and provide a quantitative link between cell survival and the integrated response of
STAT5 in the nucleus. Model predictions show that the two feedbacks CIS and SOCS3 are most
effective at different ligand concentration ranges due to their distinct inhibitory mechanisms. This
divided function of dual feedback regulation enables control of STAT5 responses for Epo
concentrations that can vary 1000-fold in vivo. Our modeling approach reveals dose-dependent
feedback control as key property to regulate STAT5-mediated survival decisions over a broad range
of ligand concentrations.
Molecular Systems Biology 7: 516; published online 19 July 2011; doi:10.1038/msb.2011.50
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Introduction
Cells interpret information encoded by extracellular stimuli
through the activation of intracellular signaling networks and
link this to cellular decisions (Kholodenko et al,2 0 1 0 ) .F e e d -
forward signaling events are counteracted by negative feedback
mechanisms facilitating adaptation, stabilityand desensitization
of input signals. Transcriptional feedback regulators that are
induced as early genes have beenidentiﬁedas major constituent
of signaling pathways such as DUSP family members for the
MAPK cascade, Smad7 and Ski family members for the TGFb/
Smad pathway and suppressor of cytokine signaling (SOCS)
proteins for JAK/STAT signaling (Legewie et al, 2008). Impor-
tantly, these transcriptional feedback regulators are down-
regulated in multiple carcinomas, implying a crucial role in
constraining growth factor and cytokine-induced signaling
(Freeman, 2000; Amit etal, 2007).Despite the ample knowledge
of the individual components involved, only little is known
aboutthespeciﬁccontributions of theseregulatorsin controlling
dose-dependent dynamic properties of signaling networks in
response to a broad range of input signals.
A prime example for a system that is exposed to extremely
variable ligand concentrations is the erythroid lineage. Key
regulator of erythropoiesis is the hormone erythropoietin
(Epo) that facilitates continuous renewal of short-lived
erythrocytes at low basal levels of B15mU/ml Epo, but also
secures compensation of blood loss through an up to 1000-fold
increase in hormone concentration in acute hypoxic condi-
tions (Jelkmann, 2004). Epo binds to the hematopoietic
cytokine receptor, the Epo receptor (EpoR), that is primarily
present on erythroid progenitor cells, but recently also has
been uncovered on tumor cells (Lappin et al, 2002; Lai et al,
2005; Liang et al, 2010). In the erythroid lineage signaling
through the EpoR is essential for survival, proliferation and
differentiation of erythroid progenitor cells at the colony
forming unit erythroid (CFU-E) stage. Stimulation of these
cellswithEpoleadstorapidbuttransientactivationofreceptor
and JAK2 phosphorylation followed by phosphorylation of the
latent transcription factor STAT5. The role of STAT5a/b in
erythropoiesis has been controversially discussed, but evi-
dence based on the analysis of STAT5
DN/DN mice that express
partially functional STAT5a/b proteins and mice completely
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Yao et al, 2006; Kerenyi et al, 2008) suggests that STAT5 is a
crucial regulator of survival and differentiation in erythroid
progenitor cells. Initial studies showed that erythroid cells
expressing STAT5
DN/DN, the hypomorphic STAT5a/b proteins,
exhibit elevated rates of apoptosis due to a failure of Bcl-xL
upregulation (Socolovsky et al, 2001). Subsequently, gener-
ated STAT5a/b
 /  mice displayed fatal defects in all lymphoid
lineages, suffered from microcytic anemia due to enhanced
apoptosis and died prenatally (Zhu et al, 2008). Recently, it
was shown that STAT5 can enable erythropoiesis even in the
absence of EpoR and JAK2 underscoring the essential role of
STAT5 in regulating apoptosis and differentiation in erythro-
poiesis (Grebien et al, 2008). However, a quantitative link
between dynamic properties of STAT5 signaling and survival
decisions remained to be established.
The STAT5-mediated responses in CFU-E cells are modu-
lated by multiple attenuation mechanisms that operate on
different time scales. Fast-acting mechanisms such as deple-
tion of Epo by rapid receptor turnover (Becker et al, 2010) and
recruitmentofthephosphataseSHP-1(Klingmu ¨lleretal,1995)
control the initial signal amplitude at the receptor level.
Transcriptional feedback regulators such as SOCS family
members operate at a slower time scale and the precise impact
on the kinetics of STAT5 signaling has not yet been
determined. Among the eight known SOCS family members,
four have been proposed in studies primarily performed with
transformed (erythro-) leukemic cell lines as putative tran-
scriptional negative regulators involved in attenuation of
EpoR-JAK2/STAT5 signaling. They include cytokine-induced
SH2-domain containing protein (CIS), SOCS1, SOCS2 and
SOCS3 (Yoshimura et al, 1995; Jegalian and Wu, 2002; Sarna
et al, 2003). Furthermore, overexpression of CIS in erythroid
progenitor cells has been shown to inhibit STAT5-mediated
survival signals (Ketteler et al, 2003). Although the inhibitory
mechanisms of these proteins are well characterized and are
partially distinct (Endo et al, 1997; Matsumoto et al, 1997;
Sasaki et al, 2000), a major open question was whether they
have redundant or speciﬁc functions in restraining STAT5
signaling in erythroid progenitor cells.
Recently, several kinetic models of JAK/STAT signaling
pathways have been established. The majority of these studies
rely on previously published data and simulations focusing on
control mechanisms of the IFN activated JAK1/JAK2/STAT1
pathwayandfeedbackbySOCS1(Zietal,2005;Soebiyantoetal,
2007) or robustness in the JAK/STAT1 pathway (Shudo et al,
2007). Up to now only few studies combine quantitative data
with mathematical models. Examples are a core model of
JAK2/STAT5 signaling investigating nucleo-cytoplasmic shut-
tling (Swameye et al,2 0 0 3 )a n da nI F N a-induced model
investigating a positive feedback loop (Maiwald et al, 2010).
Understanding how transcriptional negative feedback proteins
speciﬁcallyregulateJAK/STATpathwaydynamicsandtheextent
ofcellularresponsesrequiresmathematicalmodelsthatcombine
extensive time-resolved biochemical and phenotypic data.
In this study, we establish a transcriptional feedback model
of JAK2/STAT5 signaling in primary erythroid progenitor cells
and demonstrate that the STAT5 response integrated over time
is quantitatively linked to survival decisions. Applying the
model, we dissect the divided function of CIS and SOCS3 that
enables to conﬁne STAT5 phosphorylation levels at distinct
ligand concentration levels. Our results imply that dual
feedback regulation ensures stringent and ﬁne-tuned control
of cell survival decisions over the entire broad spectrum of
physiologically relevant Epo concentrations.
Results
Transcription-dependent regulation of STAT5
steady-state phosphorylation level
To examine the impact of transcriptional feedback regulation
on Epo-induced JAK2-STAT5 signaling, we used the generic
inhibitor of transcription actinomycin D and monitored the
time-dependent activation of the signaling network in primary
erythroid progenitors at the CFU-E stage. To conﬁrm the effect
of the actinomycin D treatment, the expression of the known
Epo-induced negative regulator CIS was monitored exempla-
rily by quantitative immunoblotting (Figure 1A and B).
Stimulation with Epo during 3h of observation leads to
transient phosphorylation of EpoR, JAK2 and STAT5 with
rapid kinetics,followedbyadecreasetoa residual steady-state
level. A comparison of time course data in the presence and
absence of inhibitor demonstrated that the steady-state
phosphorylation level of STAT5 is elevated in actinomycin D-
treated cells, indicating that attenuation of this species
involves de novo gene transcription. The phosphorylation
kinetics of the upstream signaling components, EpoR and
JAK2, however, showed no major effects compared with the
proﬁle of the untreated control. These results imply that
transcriptional feedback regulators induced as immediate
early genes have a central role in modulating the phosphor-
ylation kinetics of STAT5.
Sustained induction of the transcriptional
feedback regulators CIS and SOCS3 in primary
CFU-E cells
To identify the relevant transcriptional feedback regulators
that are involved in attenuation of Epo-induced JAK2-STAT5
signaling in addition to CIS, we performed genome-wide
expression proﬁling. Murine CFU-E cells were stimulated with
Epo and the time-resolved mRNA expression proﬁles were
analyzed to identify signiﬁcantly upregulated negative feed-
back regulators of the JAK-STATsignaling pathway (Figure 1C;
Supplementary Figure S1). The results revealed that among
the eight known SOCS proteins exclusively CIS and SOCS3
showed rapid and permanent upregulation at the mRNA level
in particular within the ﬁrst hour, which is consistent with the
presence of STAT5 consensus binding sites in the promoters of
these two genes (Matsumoto et al, 1997; Emanuelli et al,
2000). In contrast to studies in other cells that reported
upregulation of additional SOCS transcripts upon Epo stimula-
tion(JegalianandWu,2002),neitherSOCS1norSOCS2mRNA
induction was detected in the ﬁrst hours after stimulation in
CFU-E cells. This suggests that other SOCS members are either
primarily expressed in transformed cell lines or as hypothe-
sized by Sarna et al (2003) may be induced at other stages
during erythroid maturation.The slight upregulation of SOCS2
mRNA after B20h supports the latter hypothesis.
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signaling such as PIAS proteins (PIAS1-4) and hematopoietic
protein tyrosine phosphatases (PTPs) usually do not show
stimulation-dependent transcription but are constitutively
expressed. To conﬁrm this in primary erythroid progenitor
cells, we compiled expression proﬁles of the PIAS1-4 proteins
and the hematopoietic phosphatases SHP-1, SHP-2, PTP1B
and PTPRC (CD45) (Supplementary Figure S1). In line with
previous reports, stimulation-dependent induction of these
genes was not detected. Hence, CIS and SOCS3 are the two
prime candidates that can act as dual transcriptional feedback
regulators of STAT5 phosphorylation levels in erythroid
progenitor cells.
Dynamic pathway model to evaluate the biological
relevance of dual transcriptional feedback
To dissect the speciﬁc roles of CISand SOCS3 in controllingthe
JAK2-STAT5 signaling behavior, we implemented an ordinary
differential equation (ODE) model of the Epo-induced JAK2/
STAT5 pathway. Our model is divided into three submodules
describing events at the plasma membrane, in the cytoplasm
and in the nucleus (Figure 2). As model input, we assumed a
constant Epo concentration, because the depletion of Epo in
primary CFU-E cells is marginal at the high concentrations
used in this study. To explain the events at the plasma
membrane, EpoR and the tyrosine kinase JAK2 were modeled
as a complex that is present in different activation states
corresponding to the different phosphorylated species (see
Supplementary Material Section 2.2). The EpoRpJAK2 vari-
able also describes phosphorylated JAK2 that is dissociated
from the EpoR. Ligand-dependent attenuation, for instance by
receptor internalization and dephosphorylation, was summar-
ized by including deactivation of JAK2 and EpoR by the
tyrosine phosphatase SHP-1 as described in a previous model
of Epo-induced MAPK signaling in CFU-E cells (Schilling et al,
2009). Brieﬂy, the tyrosine phosphatase SHP-1, which is
constitutively expressed (Supplementary Figure S2B) has
previously been shown to require binding to the speciﬁc
phosphorylated tyrosine residue Tyr429 on the EpoR to
activate phosphatase activity (Pei et al, 1994; Klingmu ¨ller
et al, 1995). Thus, we included an activated form of SHP-1 in
our model that in turn catalyzes dephosphorylation of JAK2
and EpoR. Phosphorylation of STAT5 by JAK2 is mediated by
recruiting STAT5 to phosphotyrosine 343 and 401 of the EpoR
cytoplasmic domain that functions as a scaffold (Gobert et al,
1996; Klingmu ¨ller et al, 1996; Barber et al, 2001). Consistent
with the observation that phosphorylation of STAT5 is
impaired in the absence of docking sites (Gobert et al, 1996),
weconsideredthat the STAT5 phosphorylation by the complex
pEpoRpJAK2 must be faster than by the complex EpoRpJAK.
After dimerization, the phosphorylated STAT5 translocates
into the nucleus, binds to consensus sequences on the DNA
and migrates back into the cytoplasm to enter a new cycle of
activation (Swameye et al, 2003). These different forms of
STAT5 wereintegratedin the model by threedistinct variables,
unphosphorylated STAT5 in the cytosol (STAT5), phosphory-
lated STAT5 dimers in the cytosol (pSTAT5) and phosphory-
lated STAT5 dimers in the nucleus (npSTAT5). To enter a new
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Figure 1 Phosphorylation proﬁle of Epo-induced EpoR-JAK2-STAT5 signaling in the presence and absence of actinomycin D. (A) Time course experiment of STAT5
phosphorylation and CIS expression. Primary CFU-E cells were starved and stimulated with 5U/ml Epo after 10min pre-treatment with actinomycin D or vehicle (0.1%
dimethylsulfoxide)alone. Cellularlysateswere subjected toimmunoprecipitationandimmunoblotting withSTAT5,CIS andanti-phosphotyrosineantibodies. (B)Cellular
lysates from primary CFU-E cells treated as described were subjected to immunoprecipitation and quantitative immunoblotting with EpoR, JAK2, STAT5, CIS and anti-
phosphotyrosine antibodies. Splines (dashed lines) are displayed for visual guidance. Enhanced steady-state phosphorylation level of STAT5 is highlighted (gray). (For
immunoblots, seeSupplementaryFigure S2.)(C)Expressionproﬁling of Epo-induced JAK-STATsignaling regulators. Primary CFU-E cellswere starvedand stimulated
with 0.5U/ml Epo. RNA was subjected to microarray analysis and proﬁles of known SOCS genes were compiled. Log2-fold change of mRNA levels was calculated
relative to mean gene expression at time point t¼0h. Error bars were estimated from the gene expression variation of the biological duplicates at 0h. Only CIS and
SOCS3showasigniﬁcantregulationover timewithrespecttocontrol(P-values o0.0001,Student’st-test).(Forcontrols,seeSupplementaryFigureS1.)Sourcedatais
available for this ﬁgure at www.nature.com/msb.
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from the nucleus into the cytoplasm in our model by a single
reaction. Since various phosphatases are known to facilitate
dephosphorylation of STAT5 in the nucleus and cytoplasm
(Aoki and Matsuda, 2000; Yu et al, 2000; Hoyt et al, 2007), we
assumed constitutive inactivation of STAT5 during trafﬁc from
nucleus to cytoplasm (npSTAT5-STAT5).
Based on our experimental evidence shown in Figure 1, the
STAT5 target genes CIS and SOCS3 were included in the model
as transcriptional feedback regulators. The production of
SOCS3 and CIS transcripts was modeled using a delay that is
based on the linear chain trick (MacDonald, 1976). Based on
their previously identiﬁed molecular mechanisms of inhibi-
tion, the effect of CIS and SOCS3 was included in the model.
CIS was considered as inhibitor of STAT5 activation mediated
by the pEpoRpJAK2 complex, because it competes with STAT5
for the same pTyr binding site on the receptor. In contrast,
SOCS3 is known to bind directly to JAK2 and inhibit JAK2
activation and downstream events, i.e., phosphorylation of
EpoR and STAT5. Additionally, it can bind to the phosphory-
lated EpoR and inhibit the recruitment of STAT5 to the speciﬁc
pTyr binding sites on the EpoR as described before for CIS.
Therefore, SOCS3 in the model attenuates STAT5 phosphor-
ylation mediated by both EpoRpJAK2 and pEpoRpJAK2.
(A detailed description with references is provided in the
Supplementary Material Section 2.2.) Although the effect of
JAK2 inhibition bytranscriptional feedback regulatorswas not
signiﬁcant as shown in Figure 1, we included the inhibition of
JAK2 by SOCS3 since the effect could be obscured by other
attenuation mechanisms, i.e., deactivation of JAK2 by SHP-1.
To reduce the model complexity to the requirements of our
biological question, which is important for achieving structu-
rally and practically identiﬁable model parameters (Raue et al,
2009; Chen et al, 2010), we systematically eliminated short-
livedprotein–proteincomplexesandfastreactions.Finally,the
modelcomprised29parametersdescribing36reactionsand86
nuisance parameters, such as scaling and offset parameters of
the experimental data. Considering the total of 541 experi-
mental data points the estimation uncertainties of the model
parameters are small enough to allow for accurate model
predictions (see Supplementary Material Section 2.5).
Calibration of the dual transcriptional feedback
model
To estimate the model parameters multiple data sets of
Epo-induced JAK2/STAT5 signaling were acquired in primary
CFU-E cells using three different experimental techniques for
quantitative data generation. By quantitativeimmunoblotting,
the time-resolved activation kinetics of the experimental
observables phosphorylated and total EpoR and JAK2,
phosphorylated and total STAT5 as well as induction of CIS
and SOCS3 expression were monitored (Figure 3A). Further-
more, the initial values of all proteins were determined
(Supplementary Figure S3; Supplementary Table S1) and
dose–response experiments were performed by determining
the phosphorylation levels at the time point of maximal
activation for different Epo concentrations (Supplementary
Figures S20–S23). Since for phosphorylated proteins only
relative values were obtained by immunoblotting, we used
quantitative mass spectrometry (MS) with isotope-labeled
standard peptides to determine site-speciﬁc phosphorylation
degrees of STAT5 (Figure 3B; Supplementary Figure S4). Both
STAT5a and STAT5b are activated in response to Epo
stimulation and share functional roles in erythroid cells.
Therefore, we performed MS analysis on STAT5b as represen-
tative for both isoforms. This approach revealed that after
10min of Epo stimulation 73% of STAT5 molecules are
phosphorylated on Tyr694. In combination with the absolute
Figure 2 Mathematical model of dual negative feedback regulation of JAK2-STAT5 signaling. The model is represented as process diagram and reactions are
modulatedbyenzymecatalysis(circle-headedlines)orinhibition(bar-headedlines).Dashed-dottedlinesindicatedelayedreactionsusedforRNAtranscription.Preﬁx‘p’
represents phosphorylated species and ‘n’ represents nuclear species. Binding of the ligand Epo to its cognate receptor results in phosphorylation of JAK2, which
becomesactivated.Inasecondstep,EpoRisphosphorylatedinthecomplexEpoRpJAK2.ThepEpoRpJAK2complexwasmodeledbyconsideringdifferentsubclasses
of phosphorylated tyrosines at the receptor (see Supplementary Material Section 2.2). STAT5 is recruited by pEpoR and phosphorylated by pJAK2, dimerizes and
translocatestothenucleus.AstargetgenesofSTAT5,thenegativefeedbackproteinsCISandSOCS3areexpressed,whichinhibitthepathway.Foranextendedmodel
description, see Supplementary information.
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quantitative immunoblotting, total concentrations of phos-
phorylated STAT5 were calculated with the model. Addition-
allytotheobservationsattheproteinlevel,expressionkinetics
of CIS and SOCS3 were determined at mRNA levels using
quantitative RT–PCR to validate the data from the microarray
experiments and to improve the temporal resolution at early
time points for parameter estimation (Figure 3C).
To provide the required information content necessary to
disentangle the role of the dual negative feedback regulation,
we also performed experiments applying speciﬁc perturba-
tions. Time-resolved activation of the pathway was monitored
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Figure 3 Model calibration with experimental data of JAK2-STAT5 signaling obtained by different experimental techniques. For all experiments, primary CFU-E cells
werestarvedandstimulatedwith5U/mlEpo.Attheindicatedtimepoints,samplesweresubjectedto(A)quantitativeimmunoblotting,(B)massspectrometryanalysisor
(C) qRT–PCR. Experimental data (black circles) with estimated standard errors and trajectories of the best ﬁt (solid lines) are represented. Mass spectrometry
data represent replicates of four independent experiments. (For additional experimental data used for the model calibration, see Figure 4 and Supplementary
Figures S11–S23.) In total, 531 data points representing 18 different experimental conditions were used for model calibration. Source data is available for this ﬁgure at
www.nature.com/msb.
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SOCS3 (Figure 4). We focused on overexpression since RNAi-
mediated knockdown was not addressable with the currently
available techniques in these cells (see Supplementary
Material Section 1.2). The number of time points that could
be examined was limited since in primary cells the retroviral
transduction efﬁciency is quite low (B20%) and only
positively transduced cells were used for the experiments.
Since the level of the overexpressed proteinsis high at the start
of each experiment, already a reduction of the initial peak is
observed in addition to the impact on the steady-state
phosphorylation level. SOCS3 overexpression leads to a
reduction in the phosphorylation of JAK2, whereas CIS
overexpression does not have a major effect on JAK2
phosphorylation. This is in line with the previously proposed
inhibitory mechanisms of both proteins, i.e., SOCS3 is
blocking not only the binding of STAT5 to the receptor but
can also inhibit JAK2 via its kinase inhibitory region (KIR)
domain. CIS instead does not contain a KIR domain but is
known to compete with STAT5 for binding to the EpoR
phosphotyrosine 401 (Yoshimura et al, 1995; Ketteler et al,
2003).
Based on these data sets, the parameters were simulta-
neously estimated by maximizing the likelihood with the
MATLAB implementation of the trust-region method with user
supplied derivatives (Coleman and Li, 1996). In order to allow
for normally distributed measurement noise the likelihood
was evaluated in logarithmic concentration space (Kreutz
et al, 2007). To account for uncertainties in the parameter
estimates, the identiﬁability was investigated and 95%
conﬁdence intervals were calculated by applying the proﬁle
likelihood approach (Raue et al, 2009). The model parameters
were structurally and, in most cases, also practically identiﬁ-
able (see Supplementary Model Results 2.5). In summary,
our dual feedback regulation model was able to adequately
represent the experimental data sets for normal and perturbed
conditions, dose–response behavior of various signaling
components as well as mRNA expression and absolute
phosphorylation amounts determined based on MS analysis.
Model-based prediction of integrated STAT5
response in the nucleus correlates with
experimentally determined survival
Next, we applied the calibrated dual feedback regulation
model to examine the link of the behavior of STAT5 and the
two negative feedback regulators with regard to physiological
responses of cells. Since STAT5 is known to induce anti-
apoptotic target gene expression in CFU-E cells, we asked if a
direct relationship exists between the amount of phosphory-
lated STAT5 in the nucleus (npSTAT5) and the extent of
survival in CFU-E cells. We focused on the integral response,
which is the area under the curve, because this entity captures
both the kinetics and magnitude of the signal. It has been
demonstrated that processes with slow kinetics (i.e., genetic
networks and cell fate decisions) downstream of processes
with fast kinetics (i.e., phosphorylation-based signaling net-
works) act as integrators capable of measuring how long the
upstream signal has been on (Behar et al, 2007). Moreover,
besides cytokine responses, in MAPK signaling the integral
response of a transcription factor was used previously to link
ERK activity and DNA synthesis (Asthagiri et al, 2000). Using
the dual feedback regulation model we could quantitatively
assess the integral response of STAT5 even for very low
Epo concentrations, which are intractable in experimental
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Figure 4 Experimental data of JAK2-STAT5 signaling under perturbed conditions used for model calibration. CFU-E cells were retrovirally transduced with SHP-1
(SHP1oe), SOCS3 (SOCS3oe) or CIS (CISoe). Positively transduced cells were starved and stimulated with 5U/ml Epo for 60 or 120min, respectively. Cellular lysates
were subjected to immunoprecipitation and immunoblotting to determine activation proﬁles of JAK2-STAT5 pathway components for overexpression conditions
compared with control cells. Trajectories of the best ﬁt are indicated (solid lines) with experimental data (circles) and estimated standard errors. For pEpoR in the CIS
overexpression experiment, two data sets were combined. (For further information and additional experimental data used for the model calibration, see Figure 3 and
Supplementary Figures S11–S23.) Source data is available for this ﬁgure at www.nature.com/msb.
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instance, the STAT5 phosphorylation levels elicited by Epo
concentrations lower than 0.1U/ml are below the detection
limit of immunoblotting experiments, but sufﬁcient to
promote cell survival. We predicted the trajectory of npSTAT5
response for wild-type cells and additionally for cells over-
expressing either SOCS3 or CIS at different Epo concentrations
and calculated the area under the curve. As an example of this
procedure,themodelpredictionoftheintegralSTAT5response
at a single Epo concentration is depicted (Figure 5A). As
shownintheoverlaysofthedifferentexperimentalconditions,
SOCS3 overexpression is predicted to reduce the integral of
pSTAT5 in the nucleus much more than overexpression of CIS.
To evaluate whether the predicted integral STAT5 response
correlates with the extent of survival, we experimentally
determined the percentage of apoptotic and viable primary
CFU-E cells using the terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling (TUNEL) assay in combina-
tion with ﬂow cytometry at various Epo concentrations
for wild-type and CIS or SOCS3 overexpressing cells. Here
again, only four different Epo concentrations could be
determined in CIS and SOCS3 overexpressing cells due to the
low transduction efﬁciency that results in limited primary cell
material. A representative example at Epo¼10
 6.78U/cell is
displayed (Figure 5B), which demonstrates that SOCS3 over-
expression affects survival to a larger extent than CIS
considering similar overexpression levels (Supplementary
Figure S5A).
To systematically test if npSTAT5 is the major factor that
contributes to survival decisions, we additionally parameter-
ized the contributions to the survival signal of the different
pathway species (pEpoR, pJAK2, npSTAT5, CIS and SOCS3) in
an additive way (see Supplementary Material Section 1.1). By
comparing the contributions of various signaling components
to the anti-apoptosis response, we detect that the npSTAT5
signal contributed 499%.
As apoptosis is an all-or-none decision, we performed
simulations describing the effect of intrinsic (Supplementary
Figure S8) and extrinsic stochasticity (Supplementary Figure
S9) on npSTAT5. In both cases, the trajectory of npSTAT5 is
rather negligibly affected by noise and does not show bi-
stability. To further analyze the direct correlation between the
integral response of phosphorylated STAT5 in the nucleus and
the survival decision of erythroid progenitor cells (Figure 6C),
we investigated the induction of anti-apoptotic target genes.
First, global gene expression data wereused to identify a panel
of Epo-regulated anti-apoptotic genes. Among the preselected
candidates (Bcl-xL, BIM, Bcl-2 and Pim-1) that were pre-
viously associated with Epo-dependent regulation, exclusively
Pim-1 showed rapid and signiﬁcant induction compared with
untreated control cells (Supplementary FigureS7A). The dose-
dependent behavior of Pim-1 (Supplementary Figure S7B)
mirrored the behavior of the integral npSTAT5 response
(Figure 6C) and continuously increased over different Epo
doses in an averaged cell population. Thus, the integral of
nuclear phosphorylated STAT5 correlates with Pim-1 induc-
tion,whiletheindividualcellfatemaybeinﬂuencedbycell-to-
cell variability (Spencer et al, 2009).
As the duration of nuclear activated STAT5 that is necessary
to induce a survival response is unknown, we tested which
integration time showed the strongest correlation with the
experimentally determined survival. Interestingly, an integra-
tion time of B60min correlated best with the experimental
results as demonstrated by the log-likelihood proﬁle (Supple-
mentary Figure S5B). The overlay of the simulated npSTAT5
response integrated for 60min and the experimental survival
data of CFU-E cells at various Epo concentrations demonstrate
a close relationship of both quantities (Figure 5C). Since the
model was calibrated with biochemical experiments, in which
different cell densities were applied than in the apoptosis
assays, Epo concentrations U/ml were converted to U/cell in
order to achieve comparability of conditions. The different
effects of SOCS3 and CIS overexpression were adequately
reﬂected by the model considering the obtained conﬁdence
intervals for the parameter estimates and model trajectories
(see Supplementary Model Results 2.5).
C
B
A
Figure5 LinkingtheintegralresponseofphosphorylatedSTAT5inthenucleus
tothesurvivalrateofCFU-Ecells.(A)Thecalibratedmodelwasusedtosimulate
the integral response of phosphorylated STAT5 in the nucleus (npSTAT5) over
the broad physiological range of Epo concentrations in wild-type, CIS and
SOCS3 overexpressing (oe) cells. A representative example at Epo¼10
 6.78U/
cell is depicted. (B) TUNEL assay to determine the fraction of apoptotic cells.
Wild-type CFU-E cells and cells overexpressing SHP-1, CIS or SOCS3 were
cultured 24h in various Epo concentrations. Histograms show the representative
result of a TUNEL assay with Epo¼10
 6.78U/cell. Cells for positive control were
treated with DNaseI for 10min. (C) Overlay of scaled integral response of
npSTAT5 (60min) including 95% conﬁdence bands (shades) and experimentally
determined survival rates of CFU-E cells for wild-type cells, CIS and SOCS3
overexpressing cells (circles). Source data is available for this ﬁgure at
www.nature.com/msb.
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captured the inhibitory effects of the negative feedback
regulators over a broad Epo concentration range.
Distinct roles of feedback regulators facilitate
control of STAT5 phosphorylation level over a
broad Epo concentration range
Since CIS and SOCS3 inhibit the pathway by different
mechanisms, we asked whether they might have distinct roles
in controlling STAT5 phosphorylation over the entire range of
physiological Epo concentrations that can vary by 1000-fold
(Jelkmann, 2004). To investigate the impact of the transcrip-
tionalfeedbackregulatorsCISandSOCS3ontheSTAT5steady-
state phosphorylation level, we calculated the fold change of
STAT5 steady-state phosphorylation at 360min post Epo
stimulation for in silico cells lacking either both negative
feedback regulators (CIS-SOCS3 K.o.) or solely CIS (CIS K.o.)
or SOCS3 (SOCS3 K.o.) relative to phosphorylation level in
wild-type cells(Figure6A). The increase ofthe pSTAT5 steady-
statelevelwassimulatedoverabroadEpoconcentrationrange
percell encompassing basal (I) as wellas acute (II) conditions.
Exemplarily, the impact of the absence of both feedback
regulators or of both individually on the time course of
STAT5 phosphorylation is depicted for basal and acute Epo
I II
II I
wt (SOCS3 and CIS)
t
–14 –12 –10 –8 –6 –4 –2
Model (t=30)
Data (t=30)
–10 –9 –8 –7 –6 –5
A
BC
Figure 6 Dual negative feedback with divided function in JAK2-STAT5 signaling. (A) The steady-state level of phosphorylated STAT5 in the nucleus was simulated in
the presence of only one transcriptional negative regulator, CIS or SOCS3, and in the absence of both. The increase of pSTAT5 steady-state levels was calculated
relative to wild-type cells (black line) at t¼360min. Dashed lines indicate upper and lower 95% conﬁdence bands for the prediction. For two exemplary Epo
concentrations, (I) Epo¼10
 9U/cell and (II) Epo¼10
 6U/cell, the time proﬁles of npSTAT5 are shown. (B) Model prediction and experimental data for the increase of
phosphorylated JAK2 relative to phosphorylated Epo receptor with rising Epo concentrations at t¼30min. (C) Mechanistic scheme explaining dual negative feedback
with divided function in JAK2-STAT5 signaling for different Epo concentration ranges. The concentration dependency of the inhibitory effects of CIS and SOCS3 is
caused by the increasing fraction of phosphorylated JAK2 compared with phosphorylated EpoR. At low Epo levels, CIS mostly impacts pEpoR-dependent STAT5
activation by preventing binding of STAT5 via its SH2 domain to the speciﬁc phosphotyrosine sites on the EpoR receptor. At high Epo concentrations, SOCS3 mostly
impacts pJAK2-dependent STAT5 phosphorylation by inhibiting the activation of JAK2 via its kinase inhibitory region (KIR).
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observed an increase in the pSTAT5 steady-state level for the
double knockout simulation over the entire Epo range.
Interestingly, the single knockout simulations revealed that
CIS and SOCS3 have a distinct impact on pSTAT5 phosphor-
ylation at different Epo concentrations. This was unexpected
since both proteins are expressed to similar extents and time
frames after stimulation with Epo doses applied in the
experiments. At low Epo concentrations, the absence of CIS
resulted in an increase in the amplitude and the steady-state
level of STAT5 phosphorylation while the absence of SOCS3
had no major impact. Conversely, at high Epo concentrations
the steady-state level of STAT5 phosphorylation is increased in
the absence of SOCS3 whereas CIS has no major effect. This
synergistic action of the two feedbacks allows adjusting STAT5
phosphorylation levels over the entire concentration range of
physiological Epo concentrations from basal levels up to
extremely high values that occur under acute hypoxic stress.
To gain insights into the underlying molecular mechanism
of this dose-dependent inhibitory effect of CIS and SOCS3, we
investigated the model structure and dynamics of each species
of the pathway. By analyzing the components in dependence
of ligand doses, we identiﬁed the observable pJAK2 relative to
pEpoR as a potential explanation for the different inhibitory
effects dependent on the Epo dose. With rising Epo concentra-
tions the ratio of pJAK2 to pEpoR changes,because more JAK2
is phosphorylated relative to the EpoR (Supplementary Figure
S6). To provide experimental evidence for this model hypoth-
esis, we compared dose responses of pJAK2 relative to the
response of pEpoR determined by immunoblotting with the
model predictions (Figure 6B). Interestingly, we observed that
the model simulation of increasing pJAK2 relative to pEpoR is
ingoodagreementwiththeexperimentallydeterminedratioof
both quantities at 30minwith rising Epo concentrations.Since
SOCS3isinhibitingtheactivationofSTAT5viabothpJAK2and
pEpoR whereas CIS only blocks binding of STAT5 to the EpoR,
the impact of SOCS3 increases with increasing ratio of pJAK2
versus pEpoR. Taken together, these data and the model
suggest that SOCS3 inhibition becomes more important with
the relative increase of JAK2 phosphorylation and thus at
higher Epo doses (Figure 6C). CIS instead inhibits the binding
of STAT5 to EpoR; and thus, its inhibitory effect dominates for
lower Epo doses, when the ratio of pJAK2 to pEpoR is not
enhanced.
Discussion
Based on extensive time-resolved data sets in primary
erythroid progenitor cells and mathematical modeling, we
dissected the different contributions of the two feedback
regulators CIS and SOCS3 and identiﬁed dual transcriptional
feedback effective at discrete ligand concentrations as key
property of the EpoR-STAT5 signaling system. This result
underlines the general principle of negative feedback regula-
tion to increase control and stability of transcriptional
responses over a broad range of input values (Becskei and
Serrano, 2000; Freeman, 2000). Our observation that multiple
feedbacks are necessary to orchestrate tight regulation of
transcription factor activity from very low to very high ligand
doses suggests a new strategy of SOCS-mediated feedback
control.
Most of the previous JAK/STAT models have a complex
structure comprising a large number of variables and
literature-based parameters (Yamada et al, 2003; Zi et al,
2005; Soebiyanto et al, 2007). In this work, as an alternative
modeling strategy, a bottom-up approach was employed,
which aimsatfullyidentiﬁable parametersthatareessential to
obtain models with high predictive power (Bruggeman et al,
2002; Aldridge et al, 2006). We therefore employed a large set
of data measured under different perturbation conditions in
combination with a model structure comprising the minimal
number of parameters necessary to explain the data. Para-
meter identiﬁability was analyzed by the proﬁle likelihood
approach (Raue et al, 2009). Applying this method, we could
establish a dual negative feedback model of JAK2-STAT5
signaling with structurally and in most cases also practically
identiﬁable parameters.
Qualitatively, the important role of STAT5 as crucial
regulator of survival and differentiation of erythroid progeni-
tor cells has been established previously (Socolovsky et al,
2001; Yao et al, 2006; Grebien et al, 2008; Zhu et al, 2008). We
demonstrate that the calculated integrated response of pSTAT5
in the nucleus accurately correlates with the experimentally
determined survival of CFU-E cells, thereby providing a
quantitative link of the dependency of primary CFU-E cells
on pSTAT5 activation dynamics. In line with this, a recent
study that quantitatively determined pSTAT5 activity levels in
IL-2 induced single Tcells reported on a causal link between
enhanced pSTAT5 levels and decreased cell death (Feinerman
et al, 2010). We concluded that ﬁne-tuned changes in STAT5
activation levels are a critical determinant for cell fate
decisions. This observation is also true during an earlier
differentiation stage of the erythroid lineage. A previous study
showed that partial depletion of STAT5 from CD34þ cells bya
lentiviral RNAi approach in the presence of thrombopoietin
and stem cell factor resulted in a decrease of erythroid
progenitors (BFU-E). Conversely, overexpression of an acti-
vated STAT5a mutant strongly induced erythroid differentia-
tion (Olthof et al, 2008).
Our ﬁnding that the integral of npSTAT5 is a good predictor
for survival does not imply that survival is exclusively
depending on STAT5. The integral of STAT5 activity in the
nucleus transfers quantitative information about extracellular
ligand concentrations to downstream signals, i.e., expression
of anti-apoptotic target genes such as Pim-1 that contribute to
the ultimate cellular response. Additional pro-survival factors
such as the PI3K/AKT pathway that have been shown
previously to be involved in prevention of apoptosis in
CFU-E cells (Bouscary et al, 2003) may also contribute.
However, overexpression of constitutively active AKT could
not substitute for the apoptosis-suppressing function of the
EpoR-STAT5 pathway in JAK2
 /  erythroid cells (Ghaffari
etal,2006).Hence,thoughwecannotruleouttheinvolvement
of other pathways,our study underlines the direct relationship
of the integral STAT5 response and survival decisions of
primary erythroid progenitor cells.
Amajorbottle-neckincombiningsignaltransductionevents
with cellular phenotypes is the discrepancy in the time scale
and stimuli concentrations that are applied in the different
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mine phosphorylation events within minutes or hours after
stimulation is usually lower than the threshold of sensitivity in
assays to determine the physiological response after one or
more days. By employing our mathematical model, we were
able to compute the integrated response of STAT5 at Epo
concentrations that are beyond the threshold of biochemical
experiments. This allowed us to directly link the activation
status of the transcription factor with a cellular response. By
correlation analysis, we could identify the early signaling
phase (p1h) of STAT5 to be most predictive for survival
decisions,which wasdetermined B24hlater. Interestingly, an
earlier study that investigated a compendium of signaling
pathways and responses in TNF-, EGF- and insulin-treated
HT-29 cells revealed similar results in the predictability of
apoptosis-survival cell fate decisions by early signaling events
(Gaudet et al, 2005). The authors report that early signaling
events between 5 and 90min immediately downstream of
the receptors were more predictive than 2–8h, presumably
because information is forwarded to downstream transcrip-
tional events. Thus, we hypothesize that as a general principle
in apoptotic decisions, ligand concentrations translated into
kinetic-encoded information of early signaling events down-
stream of receptors (p1h) can be predictive for survival
decisions 24h later.
We could show by experimental data and mathematical
modeling that SOCS3 and CIS reduce the steady-state STAT5
phosphorylation level after B1h of stimulation. Our results at
a single Epo concentration are consistent with other studies
that investigated the regulation of STAT phosphorylation
dynamics by SOCS proteins. As one example, SOCS3 that is
induced upon IL-6 stimulation controls the late phosphoryla-
tion proﬁleof STAT1 and STAT3 in the liver. This was shown in
an experimental study using a conditional SOCS3 knockout,
which resulted in enhanced phosphorylation of STATs,
although the amplitude was unaffected (Croker et al, 2003).
The importance for adjusting the steady-state phase of
transcription factor activity by transcriptional feedback
regulators was shown also for other signaling pathways.
EGF-induced ERK signaling in HeLa cells is increased 1h after
stimulation when translation is blocked by cycloheximide
(Amit et al, 2007). This temporal regulation pattern, including
short-term deactivation by constitutively expressed phospha-
tases and late-phase modulation by slow transcriptional
feedbacks may evolve as a general paradigm for tightly
controlled cytokine-induced signaling pathways (Legewie
et al, 2008). The existence of multiple overlapping feedback
regulation mechanisms, each with distinct temporal charac-
teristics, ensures the effective control of the signaling
dynamics to appropriately ﬁne-tune cellular responses.
The fact that one or two SOCS family members are induced
upon stimulation appearsto be a general principle in cytokine-
induced signaling, although there is no simple relationship
between a particular cytokine and the pattern of respectively
induced SOCS mRNAs (Krebs and Hilton, 2001). Induced in a
cell type-speciﬁc and cytokine-dependent manner, SOCS
proteins can distinctively coordinate cytokine-induced re-
sponses. A prime example for the evidence that two SOCS
proteins uniquely attenuate STAT dynamics is the study of
Wormald et al (2006) showing that SOCS1 and SOCS3 regulate
STAT1 and STAT3 phosphorylation dynamics with different
kinetics. Yet, the impact of different ligand concentrations has
not been considered so far. By using model simulations to
analyze the inhibitory effects of CIS and SOCS3 on the STAT5
phosphorylation level at previously unobserved Epo concen-
trations, our results revealed that the two feedbacks are most
effective at different Epo concentration ranges. Conventional
experimental techniques, however, cannot resolve the entire
dynamic range of ligand concentrations. According to our
mathematical model, the major role of CIS is modulating
STAT5 phosphorylation levels at low, basal Epo concentra-
tions, whereas SOCS3 is essential to control the STAT5
phosphorylation levels at high Epo doses.
As potential molecular mechanism of this dose-dependent
inhibitory effect, we could identify the quantity of pJAK2
relative to pEpoR that increases with higher Epo concentra-
tions.Since SOCS3caninhibitJAK2directlyviaitsKIRdomain
to attenuate downstream STAT5 activation, SOCS3 becomes
more effective with the relative increase of JAK2 activation.
These observations are further supported by the CIS and
SOCS3 overexpression experiments that showed the strong
inhibition of JAK2 phosphorylation only by SOCS3 in primary
CFU-E cells. Moreover, in cells overexpressing SOCS3 the
STAT5 phosphorylation level was more extensively reduced
and survival was more decreased than in CIS overexpressing
cells considering similar overexpression levels.
Our ﬁndings raise the question why it is important for the
cell to tightly control the long-term steady-state signaling level
of STAT5 bytranscriptional feedback regulators over the entire
range of high and low Epo doses although the ﬁrst hour of
STAT5 activation is predictive for the survival decision. We
hypothesize that when the decision for survival has occurred,
it is essential to constrain signaling to a residual steady-state
level in order to prevent aberrant events that could lead to
uncontrolled erythroid progenitor growth. Constitutive phos-
phorylation of the JAK2/STAT5 pathway caused by activating
JAK2 mutations has a crucial role in the onset of polycythemia
vera (PV), a disease that is characterized by the formation of
endogenous colonies with Epo-independent differentiation
(Prchal and Axelrad, 1974; Weinberg et al, 1989; Kota et al,
2008). Moreover, human erythroidprogenitorcells transduced
with a constitutive phosphorylated form of STAT5 were
reported to survive, proliferate and differentiate in the absence
of Epo and in this way mimic the PV phenotype. The essential
requirement for progenitor cells to tightly constrict the Epo
input signal after 1h of stimulation over the broad range of
physiological Epo concentrations that can vary over 1000-fold
is already apparent at the upstream receptor level. Different
studieshaveshownthatactivationofEpoRandJAK2israpidly
terminated within the ﬁrst hour by dephosphorylation as well
as internalization and degradation of Epo (Gross and Lodish,
2006; Becker et al, 2010).
We propose that the transcriptional feedback proteins CIS
and SOCS3 are required to tightly adjust the phosphorylation
level of STAT5 after 1h of stimulation. This hypothesis is
supported by reports demonstrating the crucial role of SOCS3
in embryonic development. Mice lacking the SOCS3 gene
exhibitembryoniclethalityatdaysE12–16.Marineetal(1999)
showed that these mice display erythrocytosis with dramatic
expansion of erythropoiesis within the fetal liver as well as
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thedeathisassociatedwithabnormalitiesintheplacenta.Vice
versa, enforced expression of SOCS3 in vivo speciﬁcally
suppressed fetal liver erythropoiesis (Marine et al, 1999).
Moreover, a loss-of-function mutation of SOCS3 has been
proposed to contribute to the onset of myeloproliferative
disease in PV patients (Suessmuth et al, 2009). In cancer, high
input doses are mimicked by aberrant activation of JAKs
that are frequently mutated in many tumor cells. Interestingly,
there are numerous recent studies showing that in several
malignanttumorsJAKactivatingmutationsarecomplemented
bygenesilencingofSOCS3andSOCS1,thetwoSOCSmembers
which contain a KIR domain (He et al, 2003; Chim et al,
2004; Johan et al, 2005; Jost et al, 2007). This underlines
the essential role of SOCS3 to control high input doses. Thus,
the absence of SOCS3 severely impacts the growth and
survival of erythroid progenitor cells and is essential to
abrogate signaling downstream of the EpoR at long-term
steady-state phosphorylation levels upon high upstream input
conditions.
In contrast to SOCS3, our model predicts that CIS acts most
efﬁciently at a single point of the network at low ligand
concentrations. This is line with other reports that demon-
strated the major role of CIS as a speciﬁc competitive binding
inhibitor of STAT5 at the pY401 position of the EpoR
(Matsumoto et al, 1997; Verdier et al, 1998; Ketteler et al,
2002). The speciﬁc inhibition of STAT5-mediated responses by
CIS is also supported by transgenic mice that overexpress CIS.
These animals display diminished expression of STAT5-
mediated responses in growth hormone and prolactin signal-
ing, similar to STAT5
DN/DN knockout mice (Matsumoto et al,
1999).In contrast toSOCS3 knockout mice, CISknockoutmice
are viable, but show an increase in hematopoietic progenitor
cells (Kubo et al, 2003), which is in line with our model
prediction of CIS as modulatorof ﬁne-tuned pSTAT5 responses
at basal level Epo input.
In summary, our mathematical approach provided new
insights into the speciﬁc function of feedback regulation in
STAT5-mediated life or death decisions of primary erythroid
cells. We dissected the roles of the transcriptionally induced
proteins CIS and SOCS3 that operate as dual feedback with
divided function thereby facilitating the control of STAT5
activation levels over the entire range of physiological Epo
concentrations. The detailed understanding of the molecular
processes and control distribution of Epo-induced JAK/STAT
signalingcanbefurtherappliedtogaininsightsintoalterations
promoting malignant hematopoietic diseases.
Materials and methods
Isolation of TER119
  erythroid progenitor cells at
the CFU-E stage from murine fetal livers
At E13.5 Balb/c mouse embryos were dissected from the uterus of
killed females. Fetal livers were resuspended in PBS/0.3% BSA and
passed through a 40-mm cell strainer (BD Biosciences). Fetal liver cells
(FLCs) were treated with 10ml Red Blood Cell Lysis Buffer (Sigma-
Aldrich) to remove erythrocytes. For sorting TER119
  erythroid
progenitors, FLCs were incubated with rat antibodies against the
following surface markers: GR1, CD41, CD11b, CD14, CD45R/B220,
CD4 and CD8 (BD Pharmingen); Ter119 (gift from Albrecht Mu ¨ller,
Wu ¨rzburg, Germany); and with YBM/42 (gift from Suzanne M Watt,
Oxford, UK) for 20min at 41C. After washing, cells were incubated for
20min at 41C with anti-rat antibody-coupled magnetic beads and
negativelysortedwithMACScolumnsaccordingtothemanufacturer’s
instructions (Miltenyi Biotech). Sorted CFU-E cells were cultivated
for 12–14h in IMDM (Invitrogen), 30% fetal calf serum (FCS),
and 50mM b-mercaptoethanol supplemented with 0.5U/ml Epo
(Cilag-Jansen).
Microarray analysis
Freshly sorted CFU-E cells were starved for 1h in Panserin 401 (Pan
Biotech) supplemented with BSA and 50mM b-mercaptoethanol.
Subsequently, cells were stimulated with 0.5U/ml Epo or left
untreated and RNA was extracted at different time points (0, 1, 2, 3,
4, 5, 6, 7, 8, 14, 19 and 24h after Epo stimulation and 0, 1, 2, 3, 4, 5, 6
and 7h without Epo) using the RNeasy Mini Plus Kit (Qiagen). Gene
expression analysis was conducted using Affymetrix Mouse Genome
2.0 GeneChips Arrays (Affymetrix).
Normalization was performed in the R environment together with
the Bioconductor toolbox (http://www.bioconductor.org/) using the
RobustMultichip Average(RMA)forbackgroundadjustment,quantile
normalization and summarization (Irizarry et al, 2003). Subsequent
probe annotation was handled with the Affymetrix mouse4302
annotation package in Version 2.4.5. If multiple probes map to the
same Gene ID, the one with the largest test inter-quartile range (IQR)
among all time points was selected. The expression data were
deposited in the GEO database under accession number GSE26151.
All expression levels were log2 transformed and gene fold expression
was calculated with respect to the mean gene expression at 0h.
The error in fold expression ±0.43 has been estimated from the
sample IQR of the gene expression differences of the biological
duplicates at 0h.
Quantitative RT–PCR
Total RNA from 3 10
6 primary erythroid progenitor cells stimulated
with 0.5U/ml Epo was isolated using the RNeasy Mini Plus Kit
(Qiagen) according to the manufacturer’s instructions. For quantita-
tive RT—PCR, cDNA was generated with the QuantiTect Reverse
Transcription Kit (Qiagen) and analyzed using the LightCycler 480
with the hydrolysis-based Universal ProbeLibrary platform (Roche
Diagnostics). Crossing point values were calculated using the Second
Derivative Maximum method of the LightCycler 480 Basic Software
(RocheDiagnostics). PCRefﬁciencycorrectionwas performedforeach
PCR set-up individually. Relative concentrations were normalized
using HPRT as a reference gene. UPL Probes and primer sequences
were selected with the Universal ProbeLibrary Assay Design Center
(Roche Diagnostics). According to the manufacturer’s instruction, the
selected probes are intron spanning, thereby ensuring the ampliﬁca-
tion of fully matured mRNA. UPL Probes and primer sequences were
CIS_for 50-gacatggtcctttgcgtaca-30, CIS_rev 50-atgccccagtgggtaagg-30,
Probe#1 50-cctggagc-30 and SOCS3_for 50-atttcgcttcgggactagc-30,
SOCS3_rev 50-aacttgctgtgggtgaccat-30, Probe#83 50-cagccacc-30.
Plasmid constructs and retroviral transduction
cDNA of murine SOCS3, CIS or SHP-1 was cloned into pMOWSnrMCS
(Schilling et al, 2009) to yield pMOWSnr-SOCS3, pMOWSnr-CIS and
pMOWSnr-SHP-1, respectively. pMOWSnrMCS additionally contains
LNGFR (Miltenyi Biotech) that allows for magnetic bead selection of
positively transduced cells. CIS cDNA (Ketteler et al, 2003) was cloned
using EcoRI/NdeI and SOCS3 was cloned by BamHI/NdeI digestion
into pMOWSnrMCS. SHP-1 cDNA was cloned into pMOWSnrMCS by
PCR ampliﬁcation of pBS-mSHP-1 (kind gift of Lily Pao, Boston, MA,
USA). Phoenix-eco packaging cells were transiently transfected using
the calcium-phosphate method to produce retroviral particles. The
retroviral particle-containing supernatant was harvested after 24h
and ﬁltered through a 0.45-mm ﬁlter (Millipore). 3 10
6 primary
erythroid progenitor cells were transduced using 4.5ml retroviral
supernatant supplemented with 8mg/ml polybrene in a 6-well plate
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cells were cultivated for 12–14h in IMDM (Invitrogen), 30% FCS, 1%
antibiotics and 50mM b-mercaptoethanol supplemented with 0.5U/ml
Epo (Jansen-Cilag). Positively transduced cells were selected using
MACSelect LNGFR selection kit (Miltenyi Biotech) according to the
manufacturer’s instructions.
Time course experiments, cell lysis and
quantitative immunoblotting
Erythroid progenitor cells were washed three times in medium and
starved in Panserin 401 (Pan Biotech) supplemented with 50mM
b-mercaptoethanol and 1mg/ml BSA (Sigma-Aldrich) for 1h. Subse-
quently, cells (4 10
7/ml) were stimulated with 5U/ml Epo (Janssen-
Cilag) at 371C and for each time point 0.5 10
7 CFU-E cells were lysed
in 2  lysis buffer (2% NP40, 300mM NaCl, 40mM Tris–HCl pH 7.4,
20mM NaF, 1mM EDTA pH 8.0, 2mM ZnCl2 pH 4.0, 1mM MgCl2,
2mM Na 3VO4, 20% glycerol, 2mg/ml aprotinin and 200mg/ml
AEBSF).Immunoprecipitationwasperformedbyaddingtherespective
antibody, Protein A or Protein G sepharose (GE Healthcare) and the
corresponding calibrator protein GST-EpoR, SBP-JAK2, GST-STAT5b,
SBP-CIS or SBP-SOCS3 to the lysates. Antibodies used were anti-EpoR
M-20 (Santa Cruz), anti-JAK2 (Upstate/Millipore), anti-STAT5 C-17
(Santa Cruz), anti-SHP-1 C-19 (Santa Cruz), anti-CIS serum (Ketteler
et al, 2003), anti-SOCS3 (Zymed) and for immunoblotting anti-pTyr
4G10 (Upstate/Millipore), anti-CIS N-19 (Santa Cruz) and anti-SOCS3
(Abcam) as well as secondary horseradish peroxidase coupled
antibodies (anti-rabbit HRP, anti-mouse HRP, anti-goat HRP, protein
A HRP; Amersham Biosciences). Sample loading on SDS–PAGE was
randomized as described elsewhere (Schilling et al, 2005). Blots were
developed using ECL Western Blotting Detection Reagents (GE
Healthcare)and subsequentlydetectedon a Lumi-ImagerF1
TM(Roche
Diagnostics).QuantiﬁcationwasperformedusingtheLumiAnalyst3.1
software (Roche Diagnostics). Antibodies were removed by treating
the blots with b-mercaptoethanol and SDS as described previously
(Klingmu ¨ller et al, 1995).
Detection of apoptosis by TUNEL assay
Labeling of DNA strand breaks using the TUNEL assayand analysis by
ﬂow cytometry allows for quantitative analysis of apoptosis at single
cell level. Brieﬂy, cells (3 10
5cells/ml) were starved 1h and
stimulated with different Epo concentrations over 20h. 2 10
6
CFU-E cells were ﬁxed in 2% paraformaldehyde and permeabilized
with 0.1% Triton X-100, 0.1% sodium citrate for 2min. The positive
control was treated with DNase I (Roche Diagnostics) for 15min. After
washing with PBS/0.3% BSA, cells were resuspended in TUNEL
reaction mixture (Roche Diagnostics) to label free 30-OH groups of
DNA. Fluorescein-dUTP incorporated in nucleotide polymers was
detected and quantiﬁed by ﬂow cytometry using the FACSCalibur
(Becton Dickinson).
MS analysis
MS analyses were performed to measure site-speciﬁc phosphorylation
degreesofSTAT5binstarvedunstimulated(0min)andEpo-stimulated
(10min) murine CFU-E cells. Following immunoprecipitations of
endogenous STAT5, proteins were separated on 1D-PAGE and stained
with Coomassie SimplyBluet SafeStain (Invitrogen). After broad
cutting, STAT5 bands were in-gel digested with trypsin as described
(Seidleretal,2009).MSanalyseswereperformedusingananoAcquity
UPLC (Waters) coupled to a LTQ-Orbitrap XL (Thermo) as described
(Seidler et al, 2010). Data were acquired using a Top3 Data-dependent
acquisition: MS/MS spectra of the three most intense precursors with
charge X2 were recorded. Site-speciﬁc phosphorylation degrees of
STAT5b were determined by using a homologous and labeled one-
source peptide/phosphopeptide standard (Hahn et al, 2010). For
STAT5b, it was observed that the homologous standard pair used
delivers virtually identical quantitative data compared with an
isotopically labeled standard pair. MS data were analyzed using
Xcalibur 2.0.6 and MASCOT 2.2.2.
Model simulation and parameter estimation
The ODE system consists of 25 dynamic variables and was solved by
applying the CVODES solver (Hindmarsh et al, 2005) with an absolute
andrelativeaccuracyof10
 8.ThesolverwascompiledasC-executable
for MATLAB together with ODE equations. The ODE system was
evaluated for 24 different experimental conditions. For numerical
efﬁciency, these 24 independent calculations of the ODE system were
parallelized.Includingallexperimentalsettingsthemodelconsistedof
115 unknown parameters. Kinetic parameters depending on unknown
concentration scales have been disentangled from the respective
scaling parameters by suitable transformations (as described in the
Supplement). This facilitates a more efﬁcient estimation of the
unknown scaling factors. In the case of mRNA measurements of CIS
and SOCS3, no experimental information was available about the
absolute concentrations. Taking into consideration the independence
of the kinetic parameters from the scaling parameters due to the
applied parameter transformations, the internal scale of these two
mRNAcomponents was ﬁxed to one. Consequently, the model cannot
provide predictions of absolute mRNAconcentration. For the absolute
concentration of the EpoR_JAK complex, a literature value was
included as prior information for concentration scale of the receptor
complex.
The model parameters were estimated by maximum likelihood
estimation taking into account a total of 541 data points. To allow for
global parameter estimates, we scanned the parameter space,
beginning from reasonable initial guesses by taking into account the
time scale of the measurements, over orders of magnitude along the
proﬁle likelihood (Raue et al, 2009). For each step in the calculation of
the proﬁle likelihood, we applied the MATLAB implementation of the
trust-regionmethod(lsqnonlin)withusersuppliedderivatives.Forthe
calculation of the derivatives, the sensitivity equations (Leis and
Kramer, 1988) were simultaneously solved together with the original
ODE systems, which is featured by the CVODES solver efﬁciently. To
improve convergence of the estimation and due to the positive deﬁnite
nature of the parameters such as rate constant, initial concentrations,
concentration offsets and scales, and noise magnitudes, the para-
meters were estimated in logarithmic parameter space. In order to
provide for normally distributed measurement noise the likelihood
was evaluated in logarithmic concentration space (Kreutz et al, 2007)
transforming the mainly multiplicative nature of the noise to an
additive one. The magnitude of the additive measurement noise
was estimated simultaneously. For each experimental technique
and, in the case of immunoblotting, for each detection antibody
utilized, an individual noise parameter is included in the model. The
calculations of the proﬁle likelihood suggest that the global optimum
has been found.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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